Preview: Gracell Biotechnologies's Earnings
Portfolio Pulse from Benzinga Insights
Gracell Biotechnologies (NASDAQ:GRCL) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.37. The company's past performance shows a pattern of share price drops following earnings reports, despite beating EPS estimates. The company's shares were trading at $3.75 as of August 10, with a 13.44% increase over the last 52-week period.
August 11, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Gracell Biotechnologies is expected to report an EPS of $-0.37 in its upcoming earnings report. Despite beating EPS estimates in the past, the company's share price has typically dropped following earnings reports.
Gracell Biotechnologies has a history of share price drops following earnings reports, despite beating EPS estimates. This pattern, combined with the estimated EPS of $-0.37 for the upcoming report, suggests a potential negative short-term impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100